Education

• Ph.D., Sociology, University of California, Berkeley, December 1998.
  

• MA, Sociology, University of California, Berkeley, December 1990.
  
• BA, History and Sociology, University of California, Santa Cruz, June 1986.

 Current Projects

Co-Investigator (RAND). Discrimination, Health Care Attitudes, and HIV Treatment. (PI: Laura Bogart). National Institute on Mental Health (NIMH).

Co-Investigator (RAND). The Impact of Business Improvement Districts on Youth Violence. Centers for Disease Control and Prevention (CDC). (PI: John MacDonald). October 2005 to September 2009.

Co-Investigator. (RAND). Urban Congregations’ Capacity for HIV Prevention & Care. National Institute on Child and Human Development (NICHD). (PI: Kathryn Derose) May 1, 2005 to April 30, 2008.

Principal Investigator. (CSUDH). GIS, Alcohol Marketing, and Alcohol-Related Outcomes. (PI: Cohen, RAND). National Institute on Alcohol Abuse and Alcoholism (NIAAA). September 2003 to July 2007.

Principal Investigator. (CSUDH). Evaluating SHIELDS for Families HIV prevention programs. Subcontract funded by Substance Abuse and Mental Health Service Administration (SAMHSA). October 2002 to September 2007.

Principal Investigator. (RAND). Community context, SEP operations, & HIV risk among IDUs. National Institute on Drug Abuse (NIDA). September 2002 to May 2007.

Completed Projects (last 3 years) 

Principal Investigator. (DREW). Understanding Outcome Disparities in Alcohol Treatment. NIAAA. May 2003 to April 2006.

Co-Principal Investigator. (RAND). Partner-Oriented Drug Treatment & HIV Risk Reduction. PI: Martin Y. Iguchi, Ph.D. NIDA. September 2001 to December 2005.

Co-Principal Investigator & Core Director. (DREW). Drew Center for AIDS Research, Education, and Services. PI: Eric Bing, M.D., Ph.D. UARP. January 2000 to June 2005.

Investigator. (DREW). Increasing HIV Testing through a Health-Promotion Focus. (PI: Frank Galvan, Ph.D.) UARP. November 2002 to July 2005.

Investigator. (RAND). Alcohol outlets, broken windows, gonorrhea and HIV risk. (PI: Deborah Cohen, M.D., M.P.H., RAND). National Institute of Child and Human Development (NICHD). July 2002 to June 2005.

Co-Principal Investigator. (RAND). Los Angeles Adolescent Case Study. PI: Andrew Morral, Ph.D., RAND. Center on Substance Abuse Treatment (CSAT). December 1999 to April 2005.

Principal Investigator. (RAND). HIV Impacts of Local Legalization of SEPs in California. (CDC). October 2000 to September 2004.

Principal Investigator. (DREW). Malt beverage use & outcomes in a minority community. (NIAAA). September 2001 to August 2004.

Publications (last 3 years)

Peer-reviewed Journals

1.   Anderson RL, Clancey L, Flynn NM, Kral AH, Bluthenthal RN. Delivering syringe exchange services through “Satellite Exchangers”: Sacramento Area Needle Exchange. International Journal of Drug Policy. 2003;14(5/6):461-63.

2.  Riehman KS, Bluthenthal RN, Juvonen J, Morral A. Adolescent social relationships and the treatment process: Findings from quantitative and qualitative analyses. Journal of Drug Issues. 2003;33(4):865-896.

3.  Riehman KS, Kral AH, Anderson R, Flynn N, Bluthenthal RN. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. Journal of Urban Health. 2004;81(2):249-59.

4.  Bluthenthal RN, Malik MR, Grau L, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004;99(9):1136-46.

5.  Kral AH, Anderson R, Flynn N, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes. 2004;37(2):1307-1312.

 6.  Bogart L, Kral AH, Scott A, Anderson R, Flynn NM, Gilbert ML, Bluthenthal RN. Sexual risk among injection drug users recruited from syringe exchange programs. Sexually Transmitted Diseases. 2005;32(1);27-34.

 7.  Bluthenthal RN, BrownTaylor D, Guzman-Becerra N, Robinson P. Characteristics of malt liquor beer drinkers in a low-income racial minority community. Alcoholism: Clinical and Experimental Research. 2005;29(3):402-09.

 8.  Kanouse DE, Bluthenthal RN, Bogart L, Iguchi MY, Perry S, Sand K, Shoptaw S. Recruiting drug-using men who have sex with men into behavioral interventions: A two-stage approach. Journal of Urban Health. 2005;82(1 suppl 1):109-19.

 9. Bogart L, Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Condom attitudes among injection drug users participating in California syringe exchange programs. AIDS and Behavior.  2005;9(4):423-32.

10. Grau L, Bluthenthal RN, Marshall P, Singer M, Heimer R. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. AIDS and Behavior. 2005;9(4):495-504.

11. Heinzerling KG, Kral AH, Flynn NM, Anderson R, Scott A, Gilbert ML, Asch SM, Bluthenthal RN. Unmet need for recommended preventive health services among clients of California Syringe Exchange Programs: Implications for quality improvement. Drug and Alcohol Dependence. 2006;81(2):167-78.

12. Wells KB, Staunton A, Norris KC, Bluthenthal RN, Chung B, Gelberg L, Jones L, Kataoka S, Koegel P, Miranda J, Mangione CM, Patel K, Rodriguez M, Shapiro M, Wong M. Building an academic-community partnered network for clinical services research: The Community Health Improvement Collaborative (CHIC). Ethnicity & Disease. 2006;16(1 Supplement 1):S3-S17.

13. Bluthenthal RN, Jones L, Fackler-Lowrie N, Ellison M, Booker T, Jones F, McDaniel S, Moini M, Williams K, Klapp R, Koegel P, Wells KB. Witness for Wellness: Preliminary findings from a community-academic participatory research mental health initiative.  Ethnicity & Disease. 2006;16(1 Supplement 1):S18-S34.

14. Punzalan C, Paxton KC, Guentzel H, Bluthenthal RN, Staunton AD, Mejia G, Morales L, Miranda J. Seeking community input to improve implementation of a lifestyle modification program. Ethnicity & Disease. 2006;16(1 Supplement 1):S79-S88.

15. French MT, BrownTaylor D, Bluthenthal RN. Price elasticity of demand for malt liquor beer: Findings from a pilot study. Social Science and Medicine. 2006;62(9):2101-11.

16. Lorvick J, Bluthenthal RN, Scott A, Gilbert ML, Riehman KS, Anderson R, Flynn NM, Kral AH. Secondary syringe exchange among users of 23 California syringe exchange programs. Substance Use & Misuse. 2006;41(6/7):865-82.

17. Heinzerling KG, Etzioni DA, Hurley B, Holtom P, Bluthenthal RN, Asch SM. Hospital utilization for injection drug use-related soft tissue infections in urban versus rural counties in California. Journal of Urban Health. 2006; 83(2):176-181.

18. Cohen DA, Ghosh-Dastidar B, Scribner R, Miu A, Scott M, Robinson P, Farley TA, Bluthenthal RN, BrownTaylor D. Alcohol outlets, gonorrhea, and the Los Angeles civil unrest: A longitudinal analysis. Social Science and Medicine. 2006;62(9):2101-11.

19. Bluthenthal RN, Riehman KS, Jaycox L, Morral AS. Perspectives on therapeutic treatment from adolescent probationers. Journal of Psychoactive Drugs. (In press).

20. Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn NM, Kral AH. The impact of legalizing syringe exchange programs on arrest among injection drug users in California. Journal of Urban Health. (In press).

21. Jacobson, Jerry O, Robinson P, Bluthenthal RN. Understanding racial disparities in alcohol treatment outcomes: Addiction severity, demographics, and economic factors do not fully explain differences in retention. Health Services Research. (In press).

22. Galvan FH, Bluthenthal RN, Ani C, Bing EG. Increasing HIV testing among Latinos by bundling HIV testing with other test. Journal of Urban Health. (In press).  

23. Jacobson JO, Robinson R, Bluthenthal RN. A multilevel decomposition approach to estimate the role of program location and neighborhood disadvantage in racial disparities in alcohol treatment completion. Social Science and Medicine. (Accepted with revisions).

24. Stopka TJ, Marshall C, Bluthenthal RN, Webb DS, Truax SR. HCV and HIV counseling and testing integration in California: An innovative approach to increase HIV counseling and testing rates. Public Health Reports. (Accepted with revisions).

25. Bluthenthal RN, Heinzerling KG, Flynn NM, Anderson R, Kral AH. Approval of syringe exchange programs in California: Mixed results from a local approach to HIV prevention. (Revised and resubmitted) 

26. Bluthenthal RN, Ridgeway G, Schell T, Flynn NM, Anderson R, Kral AH. Are syringe exchange programs (SEPs) giving out enough syringes to lower HIV risk? The association between SEP dispensation policy and syringe coverage among injection drug users. (Invited to revise and resubmit).

Letters, Commentaries, and Reviews

1.  Kral AH, Bluthenthal RN. What is it about needle and syringe exchange programs that make them effective for preventing HIV transmission? International Journal of Drug Policy. 2003;14(5/6):361-63.

2. Cohen DA, Kanouse D, Iguchi MY, Bluthenthal RN, Galvan FR, Bing EG. Screening for STDs in non-traditional settings: Policy recommendations. International Journal of STDs and AIDS. 2005;16(8):521-27.

3. Bluthenthal RN, Heinzerling K, Martinez A, Kral, AH. Police crackdowns, societal cost, and the need for alternative approaches.  International Journal of Drug Policy. 2005;16:137-38.

PAPER PRESENTATIONS (last 3  years)

BrownTaylor D, Guzman-Berecca N, Bluthenthal RN. “Malt liquor beer use, drinking patterns, and consequences in community samples in Los Angeles, California.” Twenty-Fifth Research Society on Alcoholism. Fort Lauderdale, Florida, June 21-26, 2003.

Stopka T, Marshall C,  Bluthenthal RN, Heider J, Truax S. “HCV testing as an incentive to increase levels of HIV counseling and testing among injection drug users: The California Demonstration Project.” One Hundred and Thirty-First American Public Health Association Meeting. Philadelphia, PA. November 17, 2003.

BrownTaylor D, Waiters E, Guzman-Becerra N, Bluthenthal RN. “What the public doesn’t know: Alcohol beverage type advertising and classifications systems.” One Hundred and Thirty-First American Public Health Association Meeting. San Francisco, CA. November 17, 2003.

Heinzerling K, Etzioni DA, Bluthenthal RN, Asch SM.  “Inpatient utilization for soft tissue infections in drug users, California.” Robert Wood Johnson Clinical Scholars Program, National Meeting. Fort Lauderdale, FL. November 20-22, 2003.

Bogart L, Kral AH, Anderson R, Flynn NM, Bluthenthal RN. “Condom attitudes among injection drug uses participating in California syringe exchange programs.” Sixth Conference on AIDS Research in California and Twentieth AIDS Investigators’ Meeting. Los Angeles, CA. February 20, 2004.

Bluthenthal RN, Lorvick, J, Scott A, Riehman KS, Anderson R, Flynn NM, Kral AH. “Secondary syringe exchange among users of 23 California syringe exchange programs.” 6th Sixth Conference on AIDS Research in California and Twentieth AIDS Investigators’ Meeting. Los Angeles, CA. February 20, 2004.

Cohen DA, Bluthenthal RN, Robinson P, Farley TA, Scribner RA, Kerndt PK, Scott M, Miu A, Ghosh Dastidar B. “The impact of the 1992 Los Angeles Civil Unrest on gonorrhea.” 2004 National STD Conference. Philadelphia, PA. March 8-11, 2004.

Bluthenthal RN, Malik R, Grau L, Singer M, Marshall P, Heimer R. “Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.”  Fifteenth International Conference on the Reduction of Drug Related Harm. Melbourne, Australia. April 20-24, 2004.

Kral AH, Bluthenthal RN. “The impact of police practices on the health of IDUs in the San Francisco Bay Area.” Fifteenth International Conference on the Reduction of Drug Related Harm. Melbourne, Australia. April 20-24, 2004.

Bluthenthal RN, Anderson R, Flynn N, Kahn JG, Kral AH. “Does Adherence to Harm Reduction Practices among Syringe Exchange Programs Predict HIV Risk Behaviors among Their Clients? An Exploratory Analysis from the California Syringe Exchange Program Study (CALSEP).”  Fifteenth International Conference on the Reduction of Drug Related Harm. Melbourne, Australia. April 20-24, 2004.

Kral AH, Anderson R, Flynn N, Bluthenthal RN. “The impact of legal status on syringe exchange program operations and outcomes: Results from the California Syringe Exchange Study.” Fifteenth International Conference on the Reduction of Drug Related Harm. Melbourne, Australia. April 20-24, 2004.

Heinzerling K, Flynn N, Kral AH, Anderson R, Asch SM, Bluthenthal RN. “The role of syringe exchange programs in the delivery of preventive health services to injection drug users in California.” Twenty-seventh Society of General Internal Medicine (SGIM) Annual Meeting. Chicago, Illinois. May 12-15, 2004.

Bluthenthal RN, Jones L, Ellison MA, Koegel P, Minnium K, Lucas-Wright A, Wells K. “Witness for Wellness: A community-university participatory research mental health initiative.” Academy Health 2004 Annual Research Meeting. San Diego, California. June 6-8, 2004.

Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert M, Asch SM, Bluthenthal RN. “Syringe exchange programs and prevention services for drug users.” Complexities of Co-occurring Conditions: Harnessing Services Research to Improve Care for Mental, Substance Use, and Medical/Physical Disorder. Washington, D.C. June 23-25, 2004.

Jones L, Wells K, Bluthenthal RN, Ellison M, Koegel P, Minnium K, Lucas-Wright A, Norris K. “Witness for Wellness: A community participatory partner research initiative.”  Complexities of Co-occurring Conditions: Harnessing Services Research to Improve Care for Mental, Substance Use, and Medical/Physical Disorder. Washington, D.C. June 23-25, 2004.

Martinez A, Bluthenthal RN, Anderson R, Flynn NM, Scott A, Gilbert ML, Kral AH. “Gender differences and the impact of arrests on HIV risk behaviors of IDUs in California, 2001-2003.” Third International Conference on Urban Health. Boston, MA, October 20-22, 2004.

Bogart LM, Kral AH, Scott A, Anderson R, Flynn N, Gilbert ML, Bluthenthal RN. “Sexual risk among injection drug users in syringe exchange programs.” One Hundred and Thirty-Second American Public Health Association Annual Meeting. Washington, D.C. November 6-10, 2004.

Jones L, Wells K, Norris K, Bluthenthal RN, Wright A. “Witness for Wellness: Increasing community awareness of depression in Los Angeles.” One Hundred and Thirty-Second American Public Health Association Annual Meeting. Washington, D.C. November 6-10, 2004.

Bluthenthal RN, Koegel P, Ellison MA, Jones L, Wells K, Norris K. “Witness for Wellness: Evaluation of a community-university participatory research initiative on depression.” One Hundred and Thirty-Second American Public Health Association Annual Meeting. Washington, D.C. November 6-10, 2004.

Martinez AN, Kral AH, Anderson RL, Flynn N, Scott A, Gilbert ML, Finch BK, Bluthenthal RN. “Influence of individual and neighborhood level characteristics on arrests among IDUs in California, 2001-2003.” One Hundred and Thirty-Second American Public Health Association Annual Meeting. Washington, D.C. November 6-10, 2004.

Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn NM, Scott A, Gilbert ML, Kral AH. “Arrests and syringe confiscation among syringe exchange clients in California.” Fifth National Harm Reduction Conference. New Orleans, LA. November 11-14, 2004.

Lorvick J, Bluthenthal RN, Gee L, Anderson R, Flynn NM, Scott A, Gilbert ML, Martinez A, Kral AH. “Disposal of used syringes among syringe exchange program clients in California.” Fifth National Harm Reduction Conference. New Orleans, LA. November 11-14, 2004.

Bogart LM, Kral AH, Scott A, Anderson R, Flynn NM, Gilbert ML, Bluthenthal RN. “Engagement in anal sex among male and female injection drug users recruited from syringe exchange programs.” Fifth National Harm Reduction Conference. New Orleans, LA. November 11-14, 2004.

Bluthenthal RN, Gee L, Gilbert ML, Anderson R, Flynn NM, Scott A, Kral AH. “Are syringe exchange programs (SEPs) giving out enough syringes to lower HIV risk? Measuring the ratio of numbers of syringes received to number of injections among clients of California SEPs.” Fifth National Harm Reduction Conference. New Orleans, LA. November 11-14, 2004.

Patel K, Bluthenthal RN, Jones L, Koegel P, Wells KB. “Evaluation of a community based participatory research project: The Witness for Wellness experience.” Twenty-Eighth Society of General Internal Medicine. New Orleans, LA, May 11-14, 2005.

Galvan FH, Bing EG, Bluthenthal RN, Guzman-Becerra N, Gildon A, Ani C, Gildon Z. “Increasing HIV testing through a health promotion focus.” 2005 National HIV Prevention Conference. Atlanta, GA, June 12-15, 2005.

Guzman-Becerra N, Robinson P, Jacobson JO, Bluthenthal RN. “The contribution of alcohol treatment programs to racial disparities in completion rates: A multi-level analysis of alcohol treatment programs in Los Angeles County.” Twenty-Seventh Research Society on Alcoholism. Santa Barbara, CA, June 25-29, 2005.

Jacobson JO, Robinson P, Guzman-Becerra N, Bluthenthal RN. “Racial/Ethnic disparities in treatment modality among primary alcohol patients in Los Angeles.” Twenty-Seventh Research Society on Alcoholism. Santa Barbara, CA, June 25-29, 2005.

Robinson P, Jacobson JO, Guzman-Becerra N, Bluthenthal RN. “Does geographic access to inpatient alcohol treatment facilities matter in a large urban context? A case study in Los Angeles County.” Twenty-Seventh Research Society on Alcoholism. Santa Barbara, CA, June 25-29, 2005.

French M, BrownTaylor D, Guzman-Becerra N, Bluthenthal RN. “Price elasticity of demand for malt liquor beer: Implications for public health and policy.” 5th World Congress of the International Health Economics Association. Barcelona, Spain, July 10-13, 2005.

Martinez AN, Bluthenthal RN, Lorvick J, Kral AH. “Race and criminal justice involvement among IDUs in San Francisco, 2003-2004.” Fourth International Conference on Urban Health. Toronto, Canada, October 26-28, 2005.

Bluthenthal RN, Heinzerling K, Gilbert ML, Anderson R, Flynn NM, Scott A, Kral AH. “Local legalization of syringe exchange programs in California: Overall and program-level impacts.” 2005 International Drug Policy Reform Conference, Long Beach, CA, November 10-12, 2005.

Grau LE, Marshall PA, Singer M, Bluthenthal RN, Heimer R. “A syringe exchanged-based hepatitis prevention campaign for injection drug users in three U.S. cities.” National Viral Hepatitis Prevention Conference. Washington, D.C., December 5-9, 2005.

Bluthenthal RN, Gee L, Gilbert ML, Anderson R, Flynn NM, Scott A, Kral AH. “Are syringe exchange programs (SEPs) giving out enough syringes to lower HIV risk? Measuring the ratio of numbers of syringes received to number of injections among clients of California SEPs.” 5th National Harm Reduction Conference. New Orleans, LA. November 11-14, 2004. & One Hundred Thirty-Third Annual Meeting of the American Public Health Association, Philadelphia, PA, December 10-14, 2005.

Kral AH, Lorvick J, Bluthenthal RN. Grass-roots Politics Plus Evidence-based Research Evaluating Harm Reduction Interventions Can Affect Federal Policies. One Hundred Thirty-Third Annual Meeting of the American Public Health Association, Philadelphia, PA, December 10-14, 2005

Jacobson JO, Bingham TA, Robinson P, Harawa NT, Bluthenthal RN. “Geographic variation in behaviors related to HIV transmission: Findings from Los Angeles’ National HIV Behavioral Surveillance, 2003-04.” 21st Universitywide AIDS Research Program AIDS Investigators’ Meeting. San Mateo, California, Feb. 24, 2006.

Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH. “Do syringe dispensation policies matter? Examining the association between syringe coverage and dispensation policy among SEP clients.” Seventeenth International Conference on the Reduction of Drug Related Harm. Vancouver, Canada, April 30-May 4, 2006.

Bluthenthal RN, Forge N, Wong E, Chien S, Iguchi MY. “Drug-using network contributions to HIV risk among substance abusers entering methadone treatment. College on Problems of Drug Dependence 68th Annual Scientific Meeting, Scottsdale, Arizona, June 17-22, 2006.

Forge NG, Iguchi MY, Wong EC, Bluthenthal RN. “Racial disparities in quality of life of substance abusers in treatment.” College on Problems of Drug Dependence 68th Annual Scientific Meeting, Scottsdale, Arizona, June 17-22, 2006.

Martinez AN, Bluthenthal RN, Lorvick J, Kral AH. The influence of individual and zip code characteristics on arrest among injection drug users. 101st American Sociological Association Annual Meeting. Montreal, Quebec, Canada, August 8-14, 2006.

Iguchi MY, Kanouse DE, Bogart LM, Bluthenthal RN, Perry S, Sand K, Shoptaw S. Two-stage recruitment and behavioral interventions to reduce HIV risk in drug-using MSM. 2006 American Psychological Association Convention. New Orleans, LA, August 10-13, 2006.

Martinez AN, Bluthenthal RN, Lorvick J, Kral AH. Criminal justice involvement and HIV risk among urban poor injection drug users in San Francisco, CA. Sixteenth International AIDS Conference, Toronto, Canada, August 13-18, 2006.

Lorvick J, Martinez AN, Bluthenthal RN, Kral AH. HIV risk among heterosexual methamphetamine injectors in California, USA. Sixteenth International AIDS Conference, Toronto, Canada, August 13-18, 2006.

Derose KP, Mendel PJ, Bluthenthal RN, Hawes-Dawson J, Kanouse DE, Bejarano L, Dominguez B, Mata MA, Oden CW. Understanding urban congregations’ capacity for HIV prevention & care. One Hundred Thirty-Fourth Annual Meeting of the American Public Health Association, Boston, Massachusetts, November 4-8, 2006. (Accepted oral presentation)

 Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Final report of the California Syringe Exchange Program Study (CalSEP): Policy findings, risk assessments, and program improvement results. Sixth National Harm Reduction Conference, Oakland, California, November 9-12, 2006. (Accepted)

 Kral AH, Martinez AN, Lorvick J, Wenger L, Anderson R, Flynn NM, Bluthenthal RN. HIV risk among heterosexual methamphetamine injectors in California. Sixth National Harm Reduction Conference, Oakland, California, November 9-12, 2006. (Accepted)

 Martinez AN, Kral AH, Anderson R, Flynn NM, Bluthenthal RN. HIV risk among Mexican and Mexican American injection drug users in California. Sixth National Harm Reduction Conference, Oakland, California, November 9-12, 2006. (Accepted)

 Orchoa K, Scholar S, Hair T, Heinzerling K, Bluthenthal RN. The overdose prevention effort in Los Angeles: Affecting public perception and public policy through a summit and task force. Sixth National Harm Reduction Conference, Oakland, California, November 9-12, 2006. (Accepted)

 INVITED AND OTHER SPEAKING (last 3 years)

 “HIV risk among syringe exchange program participants: Results from the California Syringe Exchange Program Study (CalSEP).” Symposium on Substance Use, HIV and Public Health in California. California DHS Office of AIDS, Sacramento, CA, May 18, 2006.

 "Non-fatal overdoses among syringe exchange program clients in Los Angeles – 2001 to 2003.” The Los Angeles Overdose Prevention Summit. Los Angeles, CA, March 15, 2006.

 “HIV risk among minority injection drug users.” Bridging Science and Culture to Improve Drug Abuse Research in Minority Communities. NIDA sponsored conference. Atlanta, Georgia, October 24-26, 2005.

 “Harm reduction approaches to drug abuse problems.” Drug Research Symposium at Drew: “Drug  addiction is a brain disease.” Los Angeles, California, July 28, 2005.

 “California Syringe Exchange Programs in California: Update from the CALSEP Study.” The Central Point Conference: Improving Health and HIV Prevention among Substance Using Populations. Sacramento, California, February 26, 2004.

 “Impact of Police Practices on the Health of IDUs in the San Francisco Bay Area” with Alex Kral. Public Health, Research, and Law Enforcement: The Case of HIV/AIDS. New Haven, Connecticut. November 5, 2003.

 “Legalizing syringe exchange programs to improve public health.” RAND Health Board of Advisors. Washington, D.C. October 30, 2003.

 “Recruitment and Diversity Issues.” Today’s Research, Tomorrow Issues: A National Human Subjects Protections Conference. San Francisco, CA. September 23, 2003.

 “The impact of legal status on syringe exchange program operations and outcomes in California.” North-Central California Center for AIDS Research, UC Davis. Sacramento, CA. April 23, 2003.

 “Syringe Exchange Program Diversity and Correlates of HIV risk and Health Outcomes: Preliminary results from the California Syringe Exchange Program Study.” Office of AIDS, Department of Health Services, State of California. Sacramento, CA April 22, 2003.

 REVIEWS (last 3 years)

Journals

Addiction, Addiction Research and Theory, AIDS Care, AIDS and Behavior, AIDS Care Journal (2005), American Journal of Public Health, Annals of Epidemiology, Canadian Medical Association Journal, Chronic Illness, Drug and Alcohol Dependence, Expert Review of Anti-infective Therapy, Health Services Research Journal, Human Organization, International Journal of Drug Policy, Journal of Acquired Immune Deficiency Syndromes, Journal of the American Medical Association , Journal of Urban Health, Journal on Substance Abuse Treatment, Justice Research and Policy

Conferences